Search research articles
Contact Us
Filters
Showing results (371-380 of 429) with videos related to
Page
of 43
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer
Johanna C Bendell, Michael S Gordon, Herbert I Hurwitz, et al.
Respiratory Medicine
|
June 26, 2026
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Propensity Score-Matched Real-World Analysis
Pranjal Rai, Girish Bathla, Niharika Praveen, et al.
Molecular Cancer Therapeutics
|
July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
Kathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 4, 2021
Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement
Neeta Thakur, Stephanie Lovinsky-Desir, Donna Appell, et al.
Leukemia
|
December 12, 2023
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine E Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Cell Reports. Medicine
|
May 7, 2026
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results
David A Braun, Marcus S Noel, Ryan H Moy, et al.
Journal of Clinical Pharmacology
|
December 3, 2014
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib
A Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function
Chris H Takimoto, Martin A Graham, Graham Lockwood, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2014
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Pierre Maison-Blanche, Shaker Dakhil, Ari Baron, et al.
Oncoimmunology
|
July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platform
Tithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Page
of 43
Search research articles
Search
Showing results (371-380 of 429) with videos related to
Sort By:
Page
of 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 2013
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer
Johanna C Bendell, Michael S Gordon, Herbert I Hurwitz, et al.
Respiratory Medicine
|
June 26, 2026
GLP-1 Receptor Agonists in Obstructive Sleep Apnea: A Propensity Score-Matched Real-World Analysis
Pranjal Rai, Girish Bathla, Niharika Praveen, et al.
Molecular Cancer Therapeutics
|
July 13, 2018
Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response
Kathleen I Pishas, Christina D Drenberg, Cenny Taslim, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 4, 2021
Enhancing Recruitment and Retention of Minority Populations for Clinical Research in Pulmonary, Critical Care, and Sleep Medicine: An Official American Thoracic Society Research Statement
Neeta Thakur, Stephanie Lovinsky-Desir, Donna Appell, et al.
Leukemia
|
December 12, 2023
Preclinical efficacy of targeting epigenetic mechanisms in AML with 3q26 lesions and EVI1 overexpression
Christine E Birdwell, Warren Fiskus, Tapan M Kadia, et al.
Cell Reports. Medicine
|
May 7, 2026
HPK1 inhibitor NDI-101150 as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors: Phase 1/2 trial results
David A Braun, Marcus S Noel, Ryan H Moy, et al.
Journal of Clinical Pharmacology
|
December 3, 2014
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib
A Benjamin Suttle, Kenneth F Grossmann, Daniele Ouellet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function
Chris H Takimoto, Martin A Graham, Graham Lockwood, et al.
Cancer Chemotherapy and Pharmacology
|
April 11, 2014
An open-label study to investigate the cardiac safety profile of cabazitaxel in patients with advanced solid tumors
Pierre Maison-Blanche, Shaker Dakhil, Ari Baron, et al.
Oncoimmunology
|
July 6, 2026
Preclinical proof of concept for a personalized SNAP™-TIL (Specific Neo-Antigen Peptides-TIL) therapy platform
Tithi Ghosh Halder, Erin Kelley, Jorge Soria-Bustos, et al.
Page
of 43